Corpus ID: 29905234

Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

@article{Russo2004ClinicalED,
  title={Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?},
  author={Ethan B. Russo},
  journal={Neuro endocrinology letters},
  year={2004},
  volume={25 1-2},
  pages={
          31-9
        }
}
OBJECTIVES This study examines the concept of clinical endocannabinoid deficiency (CECD), and the prospect that it could underlie the pathophysiology of migraine, fibromyalgia, irritable bowel syndrome, and other functional conditions alleviated by clinical cannabis. METHODS Available literature was reviewed, and literature searches pursued via the National Library of Medicine database and other resources. RESULTS Migraine has numerous relationships to endocannabinoid function. Anandamide… Expand
55 Citations
Phytomedicines in the Treatment of Migraine
  • 9
Fibromyalgia syndrome--novel therapeutic targets.
  • 3
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
  • 12
  • PDF
Cannabinoids in the management of diffi cult to treat pain
  • 5
  • PDF
The Endocannabinoid System: An Osteopathic Perspective
  • J. McPartland
  • Medicine
  • The Journal of the American Osteopathic Association
  • 2008
  • 17
  • PDF
Cannabinoids in the management of difficult to treat pain
  • 161
  • PDF
The endocannabinoid system and migraine
  • 52
  • Highly Influenced
  • PDF
Neoteric pharmacotherapeutic targets in fibromyalgia
  • 12
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
  • G. Carlo, A. Izzo
  • Chemistry, Medicine
  • Expert opinion on investigational drugs
  • 2003
  • 139
Evaluation of drug treatment in irritable bowel syndrome.
  • N. Talley
  • Medicine
  • British journal of clinical pharmacology
  • 2003
  • 65
The Pharmacology of Current Anti‐Migraine Drugs
  • 57
Cannabinoids in pain management
  • E. Russo
  • Medicine
  • BMJ : British Medical Journal
  • 2001
  • 11
...
1
2
3
4
5
...